Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Sell
47
NUE Quote, Financials, Valuation and Earnings
Last price:
$124.52
Seasonality move
:
9.97%
Day range:
$122.73 - $124.20
52-week range:
$112.25 - $203.00
Dividend yield:
1.76%
P/E ratio:
11.92x
P/S ratio:
0.95x
P/B ratio:
1.41x
Volume:
1.2M
Avg. volume:
2.4M
1-year change:
-27.78%
Market cap:
$29B
Revenue:
$34.7B
EPS (TTM):
$10.35
Analysts' Opinion
-
Consensus RatingNucor has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $157.05, Nucor has an estimated upside of 27.31% from its current price of $123.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $125.00 representing -1.33% downside risk from its current price of $123.36.
Fair Value
-
According to the consensus of 11 analysts, Nucor has 27.31% upside to fair value with a price target of $157.05 per share.
NUE vs. S&P 500
-
Over the past 5 trading days, Nucor has overperformed the S&P 500 by 2.44% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nucor does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nucor revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Nucor reported revenues of $7.4B.
Earnings Growth
-
Nucor earnings have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Nucor reported earnings per share of $1.05.
Enterprise value:
32.1B
EV / Invested capital:
--
Price / LTM sales:
0.95x
EV / EBIT:
8.40x
EV / Revenue:
1.02x
PEG ratio (5yr expected):
--
EV / Free cash flow:
18.32x
Price / Operating cash flow:
17.02x
Enterprise value / EBITDA:
6.26x
Gross Profit (TTM):
$4.9B
Return On Assets:
7.34%
Net Income Margin (TTM):
8.05%
Return On Equity:
11.62%
Return On Invested Capital:
8.85%
Operating Margin:
6.9%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $43.2B | $35.7B | $31.4B | $8.8B | $7.4B | |
| Gross Profit | $13.9B | $8.5B | $4.9B | $1.9B | $757.9M | |
| Operating Income | $11.9B | $6.9B | $3.6B | $1.5B | $513.3M | |
| EBITDA | $12.9B | $8.2B | $5.1B | $1.9B | $804.1M | |
| Diluted EPS | $31.81 | $19.72 | $10.35 | $4.57 | $1.05 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9B | $12.1B | $14.4B | $15.9B | $13.5B | |
| Total Assets | $19.5B | $24.9B | $32.1B | $34.3B | $34.3B | |
| Current Liabilities | $2.4B | $4.8B | $4.6B | $4.3B | $5.2B | |
| Total Liabilities | $8.8B | $11B | $13.2B | $12.8B | $12.8B | |
| Total Equity | $10.7B | $14B | $18.8B | $21.5B | $21.6B | |
| Total Debt | $5.5B | $5.7B | $6.7B | $6.7B | $6.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.1B | $8.1B | $4.8B | $2.5B | $1.3B | |
| Cash From Investing | -$5.5B | -$2.6B | -$3.4B | -$460.9M | -$1.2B | |
| Cash From Financing | -$3.6B | -$2.8B | -$2.9B | -$654.9M | -$509.6M | |
| Free Cash Flow | $8.3B | $6.1B | $1.8B | $2B | $478.1M | |
NUE
Sector
Market Cap
$29B
$18.7M
Price % of 52-Week High
60.77%
60.22%
Dividend Yield
1.76%
0%
Shareholder Yield
7.18%
1.57%
1-Year Price Total Return
-27.78%
-14.61%
Beta (5-Year)
1.604
1.044
Dividend yield:
1.76%
Annualized payout:
$2.07
Payout ratio:
20.61%
Growth streak:
14 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$121.16
200-day SMA
Sell
Level
$154.11
Bollinger Bands (100)
Sell
Level
128.56 - 155.04
Chaikin Money Flow
Buy
Level
290.9M
20-day SMA
Buy
Level
$118.65
Relative Strength Index (RSI14)
Sell
Level
46.76
ADX Line
Buy
Level
19.45
Williams %R
Sell
Level
-7.8008
50-day SMA
Sell
Level
$136.38
MACD (12, 26)
Sell
Level
-3.66
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
366.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.0657)
Buy
CA Score
(Annual)
Level (1.1722)
Buy
Beneish M-Score
(Annual)
Level (-2.7672)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.9853)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products, and raw materials, the steel mills segment derives maximum revenue. The steel mills segment includes carbon and alloy steel in sheet, bars, structural and plate; steel trading businesses; rebar distribution businesses; and Nucor’s equity method investments in NuMit and NJSM.
Stock Forecast FAQ
In the current month, NUE has received 4 Buy ratings 7 Hold ratings, and 0 Sell ratings. The NUE average analyst price target in the past 3 months is $157.05.
-
Where Will Nucor Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nucor share price will rise to $157.05 per share over the next 12 months.
-
What Do Analysts Say About Nucor?
Analysts are divided on their view about Nucor share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nucor is a Sell and believe this share price will drop from its current level to $125.00.
-
What Is Nucor's Price Target?
The price target for Nucor over the next 1-year time period is forecast to be $157.05 according to 11 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is NUE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nucor is a Hold. 7 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of NUE?
You can purchase shares of Nucor via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nucor shares.
-
What Is The Nucor Share Price Today?
Nucor was last trading at $124.52 per share. This represents the most recent stock quote for Nucor. Yesterday, Nucor closed at $123.36 per share.
-
How To Buy Nucor Stock Online?
In order to purchase Nucor stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
Sell
34
NGVT alert for Jan 17
Ingevity [NGVT] is up 1.31% over the past day.
